The European Cancer Congress 2015

login
My congress planner
close
Forgot password

Create account

Searchable Programme for ECC2015

Keyword / Author:
  • 26
    SAT
    10:30 – 12:30
    Central Nervous System

    Society Session: European Association of Neuro-Oncology (EANO) – New Tools and Toys in Neuro-Oncology

    Chair: R. Soffietti (Italy)

    Chair: M. Weller (Switzerland)

    10:30
    EANO Award
    Awardee: J. Delattre (France)
    Display Presentation Details

    10:50
    Advanced molecular genetic diagnostics and the next WHO classification
    Speaker: G. Reifenberger (Germany)

    11:15
    New devices and strategies for brain tumor surgery
    Speaker: C. Watts (United Kingdom)

    11:40
    Tumour-treating fields
    Speaker: R. Stupp (Switzerland)
    Display Presentation Details

    12:05
    Neurocognitive and patient-reported outcomes and quality of life
    Speaker: M.J. Taphoorn (Netherlands)
    Display Presentation Details

  • 27
    SUN
    09:00 – 11:10
    Abstract nr
    Central Nervous System

    Proffered Paper Session: Central Nervous System

    Chair: M. Preusser (Austria)

    Chair: R. Soffietti (Italy)

    09:00
    2900
    Predictors of survival in glioblastoma patients treated with fotemustine at first relapse after Stupp regimen: Analysis of GLIOSTRY (GLIOblastoma regiSTRY) of the AINO (Italian Association of Neuro-Oncology)
    Speaker: G. Lombardi (Italy)
    Display abstract

    09:15
    2901
    Phase 2 study of VB-111, an anti-cancer gene therapy, as monotherapy followed by combination of VB-111 with bevacizumab, in patients with recurrent glioblastoma
    Speaker: A. Brenner (USA)
    Display abstract

    09:30
    2902
    GEINO-11: A prospective multicenter, open label, phase II pilot clinical trial to evaluate safety and efficacy of Dacomitinib, a pan-HER irreversible inhibitor, in patients with recurrent glioblastoma with EGFR amplification or presence of EGFRvIII mutation
    Speaker: J.M. Sepúlveda (Spain)
    Display abstract

    09:45
    2903
    Identifying the correct patient (pt) population for ABT-414: Biomarker assays for epidermal growth factor receptor (EGFR) in pts with glioblastoma (GBM)
    Speaker: M.J. van den Bent (Netherlands)
    Display abstract

    10:00
    Discussant : W. Wick (Germany)

    10:10
    2904
    Patterns of response and relapse of primary central nervous system lymphomas (PCNSL) following first line of high-dose methotrexate-based chemotherapy (hdMTX): Independent review of a prospective ANOCEF randomized phase II trial
    Speaker: E. Tabouret (France)
    Display abstract

    10:25
    2905
    Genomic characterization of brain metastases and paired primary tumors reveals branched evolution and potential therapeutic targets
    Speaker: P. Brastianos (USA)
    Display abstract

    10:40
    Discussant : M. Brada (United Kingdom)

    10:50
    26LBA
    LATE BREAKING ABSTRACT: Does valproic acid improve survival in glioblastoma? A meta-analysis of randomized trials in newly diagnosed glioblastoma
    Speaker: M. Weller (Switzerland)
    Display abstract

    11:00
    Discussant : R. Soffietti (Italy)

  • 27
    SUN
    11:30 – 12:30
    Central Nervous System

    Debate: This House Believes that MGMT Methylation Should Be Tested in All Patients with Malignant Gliomas

    Moderator: M.J. van den Bent (Netherlands)

    11:30
    Speaker in favour: M. Weller (Switzerland)

    11:45
    Speaker against: G. Reifenberger (Germany)

    12:00
    Seconder in favour: M. Hegi (Switzerland)

    12:10
    Seconder against: M. Brada (United Kingdom)

    Discussion & Voting

  • 27
    SUN
    17:00 – 18:30
    Central Nervous System

    Scientific Symposium: Onco-Immunology in Brain Tumours

    Chair: R. Stupp (Switzerland)

    Co-Chair: S. Combs (Germany)

    17:00
    The immune microenvironment in gliomas: Scientific concepts
    Speaker: M. Platten (Germany)
    Display Presentation Details

    17:20
    Immunotherapy biomarkers in extracranial tumours and their potential role in brain tumours
    Speaker: M. Preusser (Austria)
    Display Presentation Details

    17:40
    Immunotherapy – response assessment in extracranial tumours and potential issues in brain tumours
    Speaker: D. Reardon (USA)

    18:00
    Immunotherapy – current trials
    Speaker: M. Weller (Switzerland)
    Display Presentation Details

    Discussion & Roundup

  • 28
    MON
    08:00 – 08:45
    Central Nervous System

    Teaching Lecture: Antiangiogenic Therapies in Neuro-Oncology: Current State of Development

    Chair: R. Soffietti (Italy)

    Speaker: W. Wick (Germany)
    Display Presentation Details

Print all results list